Anti-type 2 diabetes and development of exenatide

Exenatide was the first approved incretin mimetic,which acts like the naturally occurring hormone glucagon like peptide-1 in vivo.Exenatide has been shown to decrease fasting and postprandial glucose levels.This review describes the anti-type 2 diabetes and development of exenatide.